MDR1 haplotypes modify BEN disease risk:: A study in Bulgarian patients with balkan endemic nephropathy compared to healthy controls

被引:18
作者
Atanasova, S
von Ahsen, N
Dimitrov, T
Armstrong, V
Oellerich, M
Toncheva, D
机构
[1] Med Univ Sofia, Dept Med Genet, BG-1431 Sofia, Bulgaria
[2] Med Univ Sofia, Dept Nephrol, BG-1431 Sofia, Bulgaria
[3] Univ Gottingen, Dept Clin Chem, D-3400 Gottingen, Germany
来源
NEPHRON EXPERIMENTAL NEPHROLOGY | 2004年 / 96卷 / 01期
关键词
MDR1; balkan endemic nephropathy; Bulgarian population; SNP analysis; haplotyping;
D O I
10.1159/000075571
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Balkan endemic nephropathy ( BEN) is a slow progressive nephropathy with frequent occurrence of uroepithelial tumors in the upper urinary tract. Genetic factors involved in xenobiotic detoxification mechanisms may cause genetic predisposition to BEN and influence the risk for this disease. Polymorphic MDR1 variants with decreased P-glycoprotein (P-gp) activity modulate the risk for renal neoplasm. We have therefore investigated the impact of MDR1 polymorphisms on BEN manifestation. Methods: The constitutional genotype frequencies of two SNPs (C3435T and G2677T) in the MDR1 gene in 112 healthy control subjects were investigated and compared with those of 96 patients with BEN. Identification of the SNPs was done with rapid cycle real-time PCR and melting curve analysis with allele-specific probes. Results: The frequency of mutant alleles was comparable in both groups. Significant differences were revealed when the MDR1 haplotypes were analyzed. Individuals with a predicted haplotype 12 (2677G/3435T) were less frequent in BEN cases ( frequency 7.3%) than in controls (16.1%, p = 0.006). We found that carriers of the haplotype 12 had a decreased risk for BEN ( OR = 0.411; 0.21 - 0.78). Conclusions: The data suggest that haplotype 12 is protective against BEN. There is no clear molecular explanation of the MDR1 haplotype effects on the protein activity, which can explain the modified effect of the haplotype 12 on BEN risk. Copyright (C) 2004 S. Karger AG, Basel.
引用
收藏
页码:7 / 13
页数:7
相关论文
共 32 条
[1]   Statistics notes - The odds ratio [J].
Bland, JM ;
Altman, DG .
BRITISH MEDICAL JOURNAL, 2000, 320 (7247) :1468-1468
[2]   BALKAN ENDEMIC NEPHROPATHY - STILL A MYSTERIOUS DISEASE [J].
BOZIC, Z ;
DUANCIC, V ;
BELICZA, M ;
KRAUS, O ;
SKLJAROV, I .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 1995, 11 (02) :235-238
[3]  
CHIN KV, 1990, J BIOL CHEM, V265, P221
[4]  
DIMITROV T, 2002, FACTA U SER MED BIOL, V9, P7
[5]   Expression of MDR1 (multidrug resistance) gene and its protein in normal human kidney [J].
Ernest, S ;
Rajaraman, S ;
Megyesi, J ;
BelloReuss, EN .
NEPHRON, 1997, 77 (03) :284-289
[6]   The P-glycoprotein multidrug transporter [J].
Fardel, O ;
Lecureur, V ;
Guillouzo, A .
GENERAL PHARMACOLOGY, 1996, 27 (08) :1283-1291
[7]   Functional polymorphisms of the human multidrug-resistance gene:: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo [J].
Hoffmeyer, S ;
Burk, O ;
von Richter, O ;
Arnold, HP ;
Brockmöller, J ;
Johne, A ;
Cascorbi, I ;
Gerloff, T ;
Roots, I ;
Eichelbaum, M ;
Brinkmann, U .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) :3473-3478
[8]   Cellular and molecular aspects of drug transport in the kidney [J].
Inui, K ;
Masuda, S ;
Saito, H .
KIDNEY INTERNATIONAL, 2000, 58 (03) :944-958
[9]   Modulation of steady-state kinetics of digoxin by haplotypes of the P-glycoprotein MDR1 gene [J].
Johne, A ;
Köpke, K ;
Gerloff, T ;
Mai, I ;
Rietbrock, S ;
Meisel, C ;
Hoffmeyer, S ;
Kerb, R ;
Fromm, MF ;
Brinkmann, U ;
Eichelbaum, M ;
Brockmöller, J ;
Cascorbi, I ;
Roots, I .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 72 (05) :584-594
[10]   ABC drug transporters:: hereditary polymorphisms and pharmacological impact in MDR1, MRP1 and MRP2 [J].
Kerb, R ;
Hoffmeyer, S ;
Brinkmann, U .
PHARMACOGENOMICS, 2001, 2 (01) :51-64